Literature DB >> 1834470

Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein.

M E Shuck1, T E Eessalu, D E Tracey, M J Bienkowski.   

Abstract

A cDNA coding for the human interleukin 1 receptor antagonist protein (IL 1Ra) was used to clone the corresponding murine cDNA. The nucleotide sequence of the open reading frame coding for the processed form of mIL 1Ra predicted a 152-residue protein that was 77% identical to human IL 1Ra. The cellular and tissue distribution of murine IL 1Ra (mIL 1Ra) transcripts showed high levels in macrophages and skin while lower levels were detected in tissues that contain significant numbers of resident macrophages. The portion of the mIL 1Ra cDNA that codes for the mature form of the protein was placed under the control of a Trp promoter and expressed in E. coli at a level of 37% of total cell protein. The expressed protein was secreted into the periplasm and was purified to homogeneity in a single step by cation-exchange chromatography. Recombinant mIL 1Ra competitively inhibited 125I-labeled IL 1 alpha binding to murine type I IL 1R present on EL4 6.1 cells (Ki value of 0.21 nM) and antagonized IL 1-stimulated co-mitogenesis in murine thymocytes (0.7 x 10(6)-1.1 x 10(6) units/mg).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834470     DOI: 10.1002/eji.1830211119

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Interactions of tumor necrosis factor with local and systemic factors in fetal rat limb bones.

Authors:  G Shankar; P H Stern
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

2.  Serum Levels of IL-1 RA Increase with Obesity and Type 2 Diabetes in Relation to Adipose Tissue Dysfunction and are Reduced After Bariatric Surgery in Parallel to Adiposity.

Authors:  Gema Frühbeck; Victoria Catalán; Beatriz Ramírez; Víctor Valentí; Sara Becerril; Amaia Rodríguez; Rafael Moncada; Jorge Baixauli; Camilo Silva; Javier Escalada; Javier Gómez-Ambrosi
Journal:  J Inflamm Res       Date:  2022-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.